URL path: Index page // Estriol (E3), Saliva

Estriol (E3), Saliva

Measurement of estriol in the saliva is used to predict preterm delivery in pregnant women at increased risk. In non-pregnant women, it is commonly used to monitor hormone levels when using estrogen-containing supplements during hormone replacement therapy.

More information

Estriol is a female steroid hormone that is highly associated with pregnancy and fetal development. The hormone DHEA-S produced in the adrenal glands of the developing fetus is metabolized in the fetal liver to 16-alpha-hydroxy-DHEA-S, which is then converted to estriol in the placenta. By the second trimester of pregnancy, about 90% of the estriol produced comes from fetal DHEA-S. Maternal circulating estriol levels increase progressively during pregnancy, peaking in the third trimester. Estriol production depends on the integrity of the fetoplacental unit. Measurement of estriol levels in the mother's saliva has been used to monitor the condition of the fetus during pregnancy. Estriol measurement is also used as part of various tests (triple and quadruple) to detect certain genetic disorders in the fetus (eg Down syndrome, spina bifida, etc.).

The normal role of estriol in non-pregnant women is not fully understood and is under investigation. In terms of estrogenic action, estriol is generally less potent than estradiol or estrone. In non-pregnant women, estriol levels are similar to pre-menopausal and post-menopausal women and are also similar to the hormone levels in men.

Changes in the levels of estriol and other estrogens may be related to the development of various cancers. Estriol also appears to be associated with certain autoimmune diseases such as multiple sclerosis and systemic lupus erythematosus, as pregnant women experience a significant reduction in symptoms during the last trimester of pregnancy. Estriol plays a role in regulating bone metabolism, lipid metabolism and protects the nerve cells (neurosteroid hormone).

Due to its weak estrogenic action, estriol is sometimes preferred for intravaginal use as an alternative to systemic estrogen therapy in the treatment of vaginal atrophy in postmenopausal women. It is also used in anti-aging creams to topically replace estrogen in the skin that is lost with age.

In the blood, the majority of estriol is bound to serum proteins, with 14-16% remaining unbound. Unbound estriol enters saliva from the blood through certain intracellular mechanisms, and salivary estriol concentrations approach plasma levels of unbound estriol. In saliva, there is virtually no binding of estriol to proteins. The correlation of estriol measurements in serum and saliva samples is extremely high.

Measurements of hormones in saliva are an excellent choice, because the collection of the sample is non-invasive and easy, without the possible complications and inconvenience of blood sampling, while ensuring the sensitivity and accuracy of the measurements.

Additional information
Share it